Capital International Sarl’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.45M | Sell |
91,517
-11,425
| -11% | -$556K | 0.09% | 152 |
|
|
2025
Q1 | $3.5M | Sell |
102,942
-83,978
| -45% | -$2.86M | 0.08% | 160 |
|
|
2024
Q4 | $7.36M | Buy |
186,920
+16,397
| +10% | +$645K | 0.17% | 117 |
|
|
2024
Q3 | $8.01M | Buy |
170,523
+21,130
| +14% | +$993K | 0.21% | 106 |
|
|
2024
Q2 | $8.07M | Buy |
149,393
+7,485
| +5% | +$404K | 0.25% | 97 |
|
|
2024
Q1 | $9.67M | Buy |
141,908
+39,234
| +38% | +$2.67M | 0.32% | 87 |
|
|
2023
Q4 | $6.43M | Buy |
102,674
+10,531
| +11% | +$659K | 0.24% | 102 |
|
|
2023
Q3 | $4.18M | Buy |
92,143
+6,708
| +8% | +$304K | 0.19% | 125 |
|
|
2023
Q2 | $4.8M | Buy |
85,435
+8,063
| +10% | +$453K | 0.22% | 124 |
|
|
2023
Q1 | $3.5M | Buy |
77,372
+18,855
| +32% | +$853K | 0.18% | 139 |
|
|
2022
Q4 | $2.38M | Buy |
58,517
+8,620
| +17% | +$350K | 0.17% | 145 |
|
|
2022
Q3 | $3.26M | Buy |
49,897
+18,618
| +60% | +$1.22M | 0.26% | 109 |
|
|
2022
Q2 | $1.9M | Buy |
31,279
+7,090
| +29% | +$431K | 0.15% | 150 |
|
|
2022
Q1 | $1.52M | Buy |
24,189
+4,027
| +20% | +$253K | 0.08% | 207 |
|
|
2021
Q4 | $1.53M | Buy |
20,162
+16,234
| +413% | +$1.23M | 0.07% | 204 |
|
|
2021
Q3 | $440K | Sell |
3,928
-274
| -7% | -$30.7K | 0.04% | 211 |
|
|
2021
Q2 | $680K | Sell |
4,202
-1,766
| -30% | -$286K | 0.06% | 192 |
|
|
2021
Q1 | $727K | Sell |
5,968
-4,175
| -41% | -$509K | 0.07% | 187 |
|
|
2020
Q4 | $1.55M | Buy |
10,143
+658
| +7% | +$101K | 0.16% | 127 |
|
|
2020
Q3 | $793K | Buy |
+9,485
| New | +$793K | 0.1% | 155 |
|